“Biomarking” the transition from genetic risk to kidney disease
Copyright policy )“Biomarking” the transition from genetic risk to kidney disease
Only some individuals carrying the high-risk APOL1 genotype go on to develop kidney disease phenotypes. In this issue of Kidney International, Nadkarni and colleagues report the associations of several biomarkers with renal outcomes in individuals with high-risk APOL1 genotypes. In the era of precision medicine, these findings should translate into improved longitudinal risk assessment for this high-risk population and might also provide additional insights regarding sites and mechanisms of APOL1 nephropathy.
- Rambam Health Care Campus Israel
- Technion – Israel Institute of Technology Israel
- University of Mary United States
Black or African American, Apolipoproteins, Genotype, Risk Factors, Humans, Genetic Predisposition to Disease, Apolipoprotein L1, Lipoproteins, HDL
Black or African American, Apolipoproteins, Genotype, Risk Factors, Humans, Genetic Predisposition to Disease, Apolipoprotein L1, Lipoproteins, HDL
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).3 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!